EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

REV1 inhibition enhances trinucleotide repeat mutagenesis

Ava Siegel iD, Daniel Almstead iD, Naveen Kothandaraman, Jessica Reich, Erica Lamkin, Joshua Victor, Aarzoo Grover, Kanayo Ikeh, Hannah Koval, Andrew Crompton, Hongjun Jang, Hyejin Lee und 6 weitere

Open Biology · 2025

DOI: 10.1098/rsob.250234 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Biology, 2025. Verfasst von Ava Siegel und 17 weiteren Autor:innen. Beteiligte Einrichtung: University of Vermont Larner College of Medicine , Burlington, VT, USA. Hauptthemen laut MEDLINE: Mutagenesis, Nucleotidyltransferases, Trinucleotide Repeats, Nuclear Proteins. Die Arbeit nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Division of Cancer Prevention, National Cancer Institute, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Trinucleotide repeat instability has been implicated in the pathogenesis of numerous neurodegenerative disorders. While germline expansions destabilize trinucleotide repeats to cause disease anticipation, somatic cell trinucleotide repeat instability drives earlier onset of symptoms and further disease progression. However, the drivers behind these repeat length changes remain unclear. Current models suggest that DNA replication slippage events and the action of genome instability pathways, such as DNA repair, cause trinucleotide repeat mutagenesis. Whether mutagenic polymerases from the translesion synthesis pathway result in trinucleotide repeat instability is unclear. Translesion synthesis polymerases are best at bypassing difficult-to-replicate DNA regions due to bulky lesions or gaps in DNA. While some effects of translesion synthesis polymerases on trinucleotide repeat instability have been explored in lower organisms, evidence in human cells is lacking. Using a quantitative green fluorescent protein (GFP) reporter with expanded CAG repeats, we show that inhibition of the translesion synthesis polymerase REV1 by its inhibitor, JH-RE-06, or siRNA knockdown increases trinucleotide repeat instability and the underlying mutability. These results suggest that REV1 protects trinucleotide repeat length mutagenesis through potential continuous DNA synthesis when replicative polymerases stall ahead of repeat secondary structures. Collectively, we present evidence of the translesion synthesis pathway’s role in trinucleotide repeat instability, with potential implications for understanding mutability mechanisms, disease biology and therapeutic targeting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MutagenesisNucleotidyltransferasesTrinucleotide RepeatsNuclear ProteinsHumansY-Family DNA PolymerasesTranslesion DNA SynthesisDNA ReplicationTrinucleotide Repeat ExpansionGenomic InstabilityDNA Repair

Stichwörter der Autor:innen

CAG repeatsJH-RE-06REV1mutagenesistranslesion synthesistrinucleotide repeat instability

Substanzen

Y-Family DNA PolymerasesNucleotidyltransferasesREV1 protein, humanNuclear Proteins

Autor:innen und Institutionen

  • University of Vermont Larner College of Medicine , Burlington, VT, USA.
  • Microbiology and Molecular Genetics, University of Vermont, Burlington, VT, USA.
  • Department of Chemistry, Duke University, Durham, NC, USA.
  • University of Vermont Cancer Center, University of Vermont, Burlington, VT, USA.
  • Department of Molecular Biology and Biophysics, University of Connecticut, Farmington, CT, USA.
  • Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, USA.

ORCID-Profile: Ava Siegel, Daniel Almstead, Nimrat Chatterjee

Förderung

  • NIGMS NIH HHS
  • Division of Cancer Prevention, National Cancer Institute
  • NIH HHS
  • NCI NIH HHS
  • National Institute of General Medical Sciences

Zitieren

APA

Siegel, A., Almstead, D., Kothandaraman, N., Reich, J., Lamkin, E., Victor, J., Grover, A., Ikeh, K., Koval, H., Crompton, A., Jang, H., Lee, H., Del Rio-Guerra, R., Korzhnev, D., Hadden, M. K., Hong, J., Zhou, P., & Chatterjee, N. (2025). REV1 inhibition enhances trinucleotide repeat mutagenesis. Open Biology. https://doi.org/10.1098/rsob.250234

Vancouver

Siegel A, Almstead D, Kothandaraman N, Reich J, Lamkin E, Victor J, et al. REV1 inhibition enhances trinucleotide repeat mutagenesis. Open Biology. 2025. doi:10.1098/rsob.250234

BibTeX
@article{Siegel2025,
  author = {Siegel, Ava and Almstead, Daniel and Kothandaraman, Naveen and Reich, Jessica and Lamkin, Erica and Victor, Joshua and Grover, Aarzoo and Ikeh, Kanayo and Koval, Hannah and Crompton, Andrew and Jang, Hongjun and Lee, Hyejin and Del Rio-Guerra, Roxana and Korzhnev, Dmitry and Hadden, M Kyle and Hong, Jiyong and Zhou, Pei and Chatterjee, Nimrat},
  title = {REV1 inhibition enhances trinucleotide repeat mutagenesis},
  journal = {Open Biology},
  year = {2025},
  doi = {10.1098/rsob.250234}
}
Kostenlos starten →